Prosthetic Use, Mobility and Daily Functioning

NCT ID: NCT04904003

Last Updated: 2022-10-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-09

Study Completion Date

2022-06-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of the project is to explore which elements of rehabilitation that influence mobility in new and experienced unilateral lower-limb amputees.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Both new and experienced unilateral lower limb amputees (LLA) describe difficulties when ambulating intentionally and independently from one place to another using prosthesis. In LLA, this decreased ability to mobilize affect daily functioning and may result in low activity-levels, impeded social participation and reduced health-related quality of life.

Both primary and secondary rehabilitation of LLA have implications for functional mobility. The consensus among health professionals is that LLA should train to improve their ability to ambulate. However, knowledge from research regarding which elements that constitute effective training and how systematic exercise affects body structures, functions, activity and participation in lower limb amputees, is limited.

There also is a lack of knowledge of how prosthetic users endure and process the challenges regarding mobility, how they adapt to the use of their prosthesis, how safe they are ambulating using the prosthesis, and how pain and psychosocial issues affect their perceived health and mobility.

The aim of this Ph.D.-project is to explore how a period of semi-standardized individualized rehabilitation originating from an evidence-based approach, affect the functional mobility of both new and experienced LLA, and how LLA process the loss of a limb and challenges during ambulation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lower Leg Amputations

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

One explorative group, one intervention group and one control group
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experienced LLA - intervention

Experienced lower-limb amputees that complete a 4-week semi-structured individualized rehabilitation regime with extensive testing before and after the intervention.

Group Type EXPERIMENTAL

Rehabilitation Intervention

Intervention Type OTHER

Strength, flexibility, endurance, balance, mobility, (self-efficacy)

Experienced LLA - controls

Experienced lower-limb amputees that will be tested with a 4-week interval. No intervention. This group will be matched to the group of experienced lower-limb amputees.

Group Type EXPERIMENTAL

Rehabilitation Intervention

Intervention Type OTHER

Strength, flexibility, endurance, balance, mobility, (self-efficacy)

New LLA learning to use prosthesis

New lower-limb amputees that complete a 8-11 weeks semi-structured individualized rehabilitation regime with extensive testing before and after the intervention.

Group Type EXPERIMENTAL

Rehabilitation Intervention

Intervention Type OTHER

Strength, flexibility, endurance, balance, mobility, (self-efficacy)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Rehabilitation Intervention

Strength, flexibility, endurance, balance, mobility, (self-efficacy)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Unilaterally amputated (above the ankle joint / under the hip joint)
* Minimum 12 months since amputation
* Have a well-adapted prosthesis before baseline measurements
* Not attended an organized, regular training program for the last 6 months
* Uses the prosthesis on a daily basis
* Participation approved by physician


* Unilaterally amputated (above the ankle joint / under the hip joint)
* Minimum 12 months since amputation
* Have a well-adapted prosthesis before baseline measurements
* Daily use of the prosthesis
* Not attended an organized, regular training program in the last 6 months
* No participation in regular and systematic training between pre- and post-testing


* Unilaterally amputated (above the ankle joint / under the hip joint)
* No prior record of use of prosthesis
* Participation approved by physician

Exclusion Criteria

* Bilaterally amputated over ankle joint
* Lack of understanding of Norwegian language (oral, written)
* Neurological disorders affecting gait function
* Skin lesion or abrasion on the stump or remaining extremity affecting mobility and function
* Other issues that complicate participation in a rehabilitation intervention
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sophies Minde Ortopedi

INDUSTRY

Sponsor Role collaborator

UniCare Bakke AS

UNKNOWN

Sponsor Role collaborator

Oslo Metropolitan University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Terje Gjøvaag, PhD.

Role: STUDY_DIRECTOR

Associate professor and Head of research group

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Unicare Bakke

Halden, Akershus, Norway

Site Status

OsloMet

Oslo, , Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2018/2577

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.